Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Voelkel-Johnson

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Cancer Biology & Therapy|July 25, 2003
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cellsChristina Voelkel-Johnson
Nature Reviews. Urology|June 15, 2011
TRAIL-mediated signaling in prostate, bladder and renal cancerChristina Voelkel-Johnson
Seminars in Cancer Biology|January 11, 2021
Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumorsChristina Voelkel-Johnson
Journal of Visualized Experiments : Jove|December 12, 2013
An orthotopic bladder cancer model for gene delivery studiesLaura Kasman, Christina Voelkel-Johnson
Advances in Cancer Research|July 30, 2020
Giants and monsters: Unexpected characters in the story of cancer recurrenceShai White-Gilbertson, Christina Voelkel-Johnson
BMC Cancer|May 17, 2011
Adenoviral infectivity of exfoliated viable cells in urine: implications for the detection of bladder cancerAnuradha Murali, Laura Kasman, Christina Voelkel-Johnson
Prostate Cancer|January 31, 2012
Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cellsLaura Kasman, Georgiana Onicescu, Christina Voelkel-Johnson
BMC Cancer|January 11, 2005
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenograftsAhmed El-Zawahry, John McKillop, Christina Voelkel-Johnson
Cytokine & Growth Factor Reviews|March 21, 2008
Transformation, translation and TRAIL: an unexpected intersectionShai White-Gilbertson, Semyon Rubinchik, Christina Voelkel-Johnson
Cancer Biology & Therapy|December 24, 2002
Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expressionMargaret M Kelly, Brian D Hoel, Christina Voelkel-Johnson
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Cancer Biology & Therapy|July 25, 2003
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cellsChristina Voelkel-Johnson
Nature Reviews. Urology|June 15, 2011
TRAIL-mediated signaling in prostate, bladder and renal cancerChristina Voelkel-Johnson
Seminars in Cancer Biology|January 11, 2021
Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumorsChristina Voelkel-Johnson
Journal of Visualized Experiments : Jove|December 12, 2013
An orthotopic bladder cancer model for gene delivery studiesLaura Kasman, Christina Voelkel-Johnson
Advances in Cancer Research|July 30, 2020
Giants and monsters: Unexpected characters in the story of cancer recurrenceShai White-Gilbertson, Christina Voelkel-Johnson
BMC Cancer|May 17, 2011
Adenoviral infectivity of exfoliated viable cells in urine: implications for the detection of bladder cancerAnuradha Murali, Laura Kasman, Christina Voelkel-Johnson
Prostate Cancer|January 31, 2012
Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cellsLaura Kasman, Georgiana Onicescu, Christina Voelkel-Johnson
BMC Cancer|January 11, 2005
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenograftsAhmed El-Zawahry, John McKillop, Christina Voelkel-Johnson
Cytokine & Growth Factor Reviews|March 21, 2008
Transformation, translation and TRAIL: an unexpected intersectionShai White-Gilbertson, Semyon Rubinchik, Christina Voelkel-Johnson
Cancer Biology & Therapy|December 24, 2002
Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expressionMargaret M Kelly, Brian D Hoel, Christina Voelkel-Johnson
Pageof 7